Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Avansor Pharma Oy
OY
Active
Y-tunnus 1835834-2
Tekniikantie 14, 02150
Espoo
Wholesale of pharmaceutical and medical goods
·
NACE 4646
Est. 2003 · 23 years old
— employees
www.avansorpharma.fi
Share
Finland
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Avansor Pharma Oy
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
EUR millions
0M
1M
2M
3M
5M
2M
2021
3M
2022
3M
2023
4M
2024
3M
2025
EBITDA
EUR millions
3M
2M
1M
1M
0M
0M
2021
0M
0%
2022
0M
0%
2023
2M
+200%
2024
0M
-100%
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
2 291
2 753
2 974
3 938
3 267
Staff expenses
−97
−114
−196
−167
−169
EBITDA
199
201
291
1 554
27
Depreciation & amort.
—
−7
−37
−10
−9
EBIT
199
195
253
1 544
18
Net financials
11
−1
−3
16
34
Profit before tax
209
194
250
1 560
52
Tax
18
44
76
466
148
Net profit
192
149
174
1 094
−96
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
4 273
4 506
5 080
6 677
312
Equity
4 010
4 109
4 184
5 128
4 882
Long-term debt
—
—
0
0
0
Short-term debt
263
397
896
1 549
1 317
Total debt
263
397
896
1 549
1 317
Financial ratios
5-year trend
EBITDA-margin
0.8%
This company
15.8%
Market median
-95% vs market
2021
2025
Soliditetsgrad
1563.7%
This company
38.2%
Market median
+3993% vs market
2021
2025
Egenkapitalforrentning
-2.0%
This company
18.4%
Market median
-111% vs market
2021
2025
Nettoresultatgrad
-2.9%
This company
8.1%
Market median
-136% vs market
2021
2025
Aktivomsætning
10.46×
This company
1.12×
Market median
+834% vs market
2021
2025
Gæld/egenkapital
-0.94×
This company
0.62×
Market median
+252% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
View
PDF
More on Avansor Pharma Oy
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
